… with angiotensin converting enzyme inhibitors and ARBs is standard of care in many hypertensive and cardiovascular diseases … When combined with low-dose ARB, C21 enhanced the …
CITATION STYLE
Vukelic, V. L., & Orias, M. (2015). Novel Molecules. In Chronic Kidney Disease and Hypertension (pp. 47–55). Springer New York. https://doi.org/10.1007/978-1-4939-1982-6_5
Mendeley helps you to discover research relevant for your work.